Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Andrologia ; 48(2): 125-36, 2016 Mar.
Article in English | MEDLINE | ID: mdl-25904411

ABSTRACT

Moringa oleifera L. is a medicinal plant with potential antioxidant property. This study was aimed at investigating the chemoprotective effect of Moringa oleifera leaf extract (MOE) on cyclophosphamide (CP)-induced testicular toxicity. Two-week-old male Swiss albino mice were intraperitoneally injected with phosphate-buffered saline, 50 mg kg(-1) of CP and 25 mg kg(-1) of MOE. In combination treatment, mice were injected with 25 mg kg(-1) of MOE 24 h prior to CP injection, 24 h prior and post-CP injection and 24 h post-CP injection for 5 consecutive days (10 mg kg(-1) ). Six weeks later, mice were sacrificed to assess epididymal sperm parameters. MOE alone did not have any significant effect on sperm parameters. However, acute injection of CP resulted in significant decline in motility (P < 0.001), increase in head abnormality (P < 0.01) and DNA damage (P < 0.05). Combining MOE with CP increased the sperm density, motility and reduced head defect and DNA damage, irrespective of the schedule and dosage of MOE. Administration of MOE prior to CP significantly elevated the level of superoxide dismutase and catalase with concomitant decrease in lipid peroxidation in the testicular tissue. In conclusion, MOE may have potential benefit in reducing the loss of male gonadal function following chemotherapy.


Subject(s)
Antineoplastic Agents, Alkylating/toxicity , Antioxidants/pharmacology , Cyclophosphamide/toxicity , DNA Damage/drug effects , Moringa oleifera , Plant Extracts/pharmacology , Sperm Motility/drug effects , Spermatozoa/drug effects , Animals , Catalase/drug effects , Catalase/metabolism , Epididymis , Lipid Peroxidation/drug effects , Male , Mice , Plant Leaves , Puberty , Spermatozoa/cytology , Spermatozoa/metabolism , Superoxide Dismutase/drug effects , Superoxide Dismutase/metabolism
2.
Intern Med J ; 41(5): 399-407, 2011 May.
Article in English | MEDLINE | ID: mdl-21299783

ABSTRACT

AIMS: To obtain accurate incidence data for myelodysplasia in the Wellington Region of New Zealand (NZ), to analyse the treatment these patients received and to review their outcome. METHODS: Patients diagnosed with myelodysplasia between 1 January 2002 and 1 September 2007 were identified. Their bone marrow biopsy, clinical record, cytogenetic analysis and transfusion record were analyzed. RESULTS: Seventy myelodysplastic patients were identified yielding an incidence of 2.75 per 100,000 per year. Median survival was 23 months, and transformation to acute leukaemia occurred in five patients (7.1%). Three patients (4.3%) received an allogeneic bone marrow transplant, and five patients (7.1%) received disease modifying treatment. Fifty-six of 70 patients (80%) received a blood transfusion, a mean of 32.9 red blood cell (RBC) units were transfused to each transfusion recipient during the study period of 68 months. One of 70 patients developed a clinical syndrome of iron overload. CONCLUSION: The incidence of myelodysplasia in Wellington, NZ is similar to incidence figures from previously published studies. The treatment these patients received was predominantly supportive through RBC transfusion. Effective iron chelation therapy measures were not used although there appeared to be a low incidence of clinical iron overload in the study population. The data in this study will be available for comparison with future studies to assess trends in incidence, treatment and outcome in myelodysplastic patients in NZ.


Subject(s)
Myelodysplastic Syndromes/epidemiology , Aged , Aged, 80 and over , Bone Marrow Examination , Erythrocyte Transfusion , Ethnicity/statistics & numerical data , Female , Ferritins/analysis , Hematopoietic Stem Cell Transplantation , Humans , Incidence , Kaplan-Meier Estimate , Male , Melphalan/therapeutic use , Middle Aged , Myelodysplastic Syndromes/ethnology , Myelodysplastic Syndromes/genetics , Myelodysplastic Syndromes/pathology , Myelodysplastic Syndromes/therapy , New Zealand/epidemiology , Pyridoxine/therapeutic use , Transplantation, Homologous , Treatment Outcome
4.
Arch Biochem Biophys ; 374(1): 59-65, 2000 Feb 01.
Article in English | MEDLINE | ID: mdl-10640396

ABSTRACT

Phenotypically stable young adult bovine articular chondrocytes suspended in beads of alginate gel were first cultured for 5 days, using daily changes of medium containing 10% fetal bovine serum and supplements. The cells in the beads were then maintained in culture for a further 3 days in the presence or absence of interleukin-1alpha at 1 ng/ml in the daily change of medium. The exposure to interleukin-1alpha caused the incorporation of (35)S-sulfate into the predominant cartilage proteoglycan, aggrecan, to decrease by approximately 60%. In addition, proteoglycans that had accumulated into the cell-associated matrix during the first 5 days of culture in the absence of interleukin-1alpha moved into the matrix further removed from the cells and from there into the medium. In contrast, the exposure to interleukin-1alpha was found to markedly promote the rate of synthesis of hyaluronan, especially during the first 24 h. Over the 3 days of culture in the presence of interleukin-1alpha, a large proportion of the newly synthesized hyaluronan molecules, as well as those that had previously become residents of the cell-associated matrix, moved out of this compartment and appeared to become permanent residents of the further removed matrix. These results demonstrate that exposure of young adult articular chondrocytes to interleukin-1alpha has profound effects on the metabolism of hyaluronan, a molecule that plays a critical role in the retention of proteoglycan molecules in the matrix. Importantly, the results suggest that exposure of chondrocytes to interleukin-1 in inflamed joints, such as occurs in rheumatoid arthritis, leads to the rapid loss of coordination of the synthesis of aggrecan and hyaluronan, two of the critical constituents of the proteoglycan aggregate. In addition, we present evidence that these interleukin-1-induced effects differentially alter the metabolism of hyaluronan in the metabolically active cell-associated matrix and the metabolically inactive matrix further removed from the chondrocytes.


Subject(s)
Chondrocytes/drug effects , Extracellular Matrix Proteins , Hyaluronic Acid/metabolism , Interleukin-1/pharmacology , Proteoglycans/drug effects , Aggrecans , Alginates , Animals , Cartilage, Articular/cytology , Cattle , Cells, Cultured , Chondrocytes/cytology , Chondrocytes/metabolism , Dose-Response Relationship, Drug , Extracellular Matrix/chemistry , Extracellular Matrix/drug effects , Glucuronic Acid , Hexuronic Acids , Lectins, C-Type , Proteoglycans/metabolism , Rats
5.
Int J Cancer ; 83(5): 679-84, 1999 Nov 26.
Article in English | MEDLINE | ID: mdl-10521807

ABSTRACT

Carcinogenicity of pan masala, a dry powdered chewing mixture of areca nut, catechu, lime, spices and flavoring agents was evaluated by means of the long-term animal bio-assay 6- to 7-week old male and female S/RVCri mice were divided randomly into intermediate and lifetime exposure groups and fed normal diet without pan masala-(zero dose) or diet containing 2.5% and 5% pan masala. Animals in the intermediate-exposure group (n = 10/gender/dose group) were killed after 6, 12 or 18 months of treatment, while those in the lifetime-exposure group (n = 54/gender/dose group) were killed when moribund or at the termination of the experiment at 24 months. Several tissues were processed for histopathological examination. The body weight and survival rate of mice fed pan masala were lower than that of the controls. Histopathological observations of tissues from control animals did not reveal any neoplastic alterations. However, lifetime feeding of pan masala induced adenoma of the liver, stomach, prostate and sebaceous glands, also forestomach papilloma, liver hamartoma, hepatoma and hemangioma, carcinoma of the forestomach, adenocarcinoma of the lung and liver, and testicular lymphoma. Neoplastic lesions appeared mainly in the liver (n = 13), stomach (n = 3) and lung (n = 8). Lung adenocarcinoma, the most frequent malignant tumor type, was observed in 2/120 mice in the intermediate-exposure group and in 8/216 animals in the lifetime-exposure group. Statistical analysis of tumor-induction data revealed a significant dose-related increase in lung adenocarcinomas but not in liver and stomach neoplasms indicating that lung is the major target tissue for the carcinogenic action of pan masala.


Subject(s)
Areca/adverse effects , Catechin/adverse effects , Flavoring Agents/adverse effects , Flour/adverse effects , Food, Formulated/adverse effects , Plants, Medicinal , Spices/adverse effects , Animals , Carcinogenicity Tests , Female , Male , Mice , Neoplasms, Experimental/etiology , Neoplasms, Experimental/pathology , Precancerous Conditions/etiology , Precancerous Conditions/pathology , Time Factors
6.
Int J Cancer ; 75(2): 225-32, 1998 Jan 19.
Article in English | MEDLINE | ID: mdl-9462712

ABSTRACT

Pan masala, a dry powdered mixture of areca nut, catechu, lime, unspecified spices and flavoring agents, has gained widespread popularity as a chewing substitute in India. In this study, the carcinogenic and tumor-promoting potential of an ethanolic pan masala extract (EPME) was determined using skin of S/RVCri-ba mice and forestomach and esophagus of ICRC mice as the target tissues. Carcinogenic activity of pan masala was tested by painting the mouse skin for 40 weeks with EPME or by gavage feeding for 6 months. Following initiation with 9,10-dimethylbenz(a)anthracene (DMBA), carcinogenesis of mouse skin was promoted with different doses of EPME, while gastric- and esophageal-tumor-promoting activity was determined by administering EPME by gavage to animals initiated with diethylnitrosamine (DEN). The ability of EPME to effect progression of skin papilloma to carcinoma and cutaneous alterations after a single or multiple EPME treatment were also evaluated. EPME at 25 mg per dose promoted skin-papilloma formation between 30 and 40 weeks of treatment and enhanced the rate of conversion of papilloma to carcinoma. Induction of mild epidermal hyperplasia, dermal edema, increase in epidermal mitotic activity and the rate of epidermal and dermal DNA synthesis by EPME correlated well with its skin-tumor-promoting potential. In ICRC mice, EPME was inactive as a complete carcinogen, but effectively promoted the development of forestomach and esophageal papilloma and carcinoma in a concentration-dependent manner. The tumor incidence at 25 mg EPME per dose was comparable with that obtained in the 12-O-tetradecanoylphorbol-13 acetate(TPA)-treated group. The findings indicate that habitual pan-masala use may exert carcinogenic and co-carcinogenic influence.


Subject(s)
Areca , Esophageal Neoplasms/chemically induced , Plants, Medicinal , Skin Neoplasms/chemically induced , Stomach Neoplasms/chemically induced , 9,10-Dimethyl-1,2-benzanthracene , Animals , Cocarcinogenesis , Esophageal Neoplasms/pathology , Female , Male , Mice , Mice, Hairless , Mice, Inbred ICR , Powders , Skin Neoplasms/pathology , Stomach Neoplasms/pathology , Tetradecanoylphorbol Acetate/toxicity
7.
Indian J Exp Biol ; 29(5): 401-6, 1991 May.
Article in English | MEDLINE | ID: mdl-1916936

ABSTRACT

Aqueous, caffeine free and tannin fractions of commercial tea and tannic acid were tested for mutagenicity in Ames test. Tea fractions of tannic acid were non mutagenic in strains TA 100, TA 98, TA 1535 and TA 1538 of Salmonella typhimurium with or without metabolic activation (rat-S9 mix) at different doses tested. In strain TA 98 the above tea fractions and tannic acid inhibited the S9 mix mediated mutagenicity of tobacco in a dose dependent manner. The different tea fractions at 60 degrees C, did not increase the tumor incidence in Swiss mice by gavage feeding. They also failed to produce tumors when injected subcutaneously. Caffeine free tea extract decreased the tobacco induced liver tumors but had no effect on lung tumors. The same fraction was ineffective in hexachlorocyclohexane induced liver tumors in Swiss mice.


Subject(s)
Carcinogens/toxicity , Mutagens/toxicity , Tea/toxicity , Animals , Biotransformation , Male , Mice , Plant Extracts , Plants, Toxic , Salmonella typhimurium/drug effects , Nicotiana
8.
Mutagenesis ; 4(3): 200-4, 1989 May.
Article in English | MEDLINE | ID: mdl-2659937

ABSTRACT

Hydroxychavicol and eugenol are the phenolic compounds isolated from betel leaf (piper betel). The modulation of nitrosation of methylurea by sodium nitrite at pH 3.6 and 30 degrees C was studied. The formation of mutagenic N-nitrosomethylurea was monitored by checking the mutagenicity of reaction mixture in Salmonella typhimurium strain TA100 and TA1535 without S9 mix. Hydroxychavicol and eugenol exhibit dose-dependent suppression of nitrosation in vitro without affecting the survival of the bacteria. Pre- or post-treatment of bacterial cells from S. typhimurium strains TA100 and TA1535 with phenolics did not modify the mutagenicity of nitrosomethylurea. The blocking of hydroxy group(s) in the benzene ring by acetylation abolishes the anti-nitrosating activity of the molecule(s). The nitrosation inhibition by hydroxychavicol is through scavenging of nitrite ions in the media, thus making them non-available for the nitrosation of methylurea.


Subject(s)
Areca/analysis , Eugenol/analogs & derivatives , Nitroso Compounds/metabolism , Plants, Medicinal/analysis , Eugenol/isolation & purification , Eugenol/pharmacology , Methylnitrosourea/antagonists & inhibitors , Methylnitrosourea/metabolism , Molecular Structure , Mutagenicity Tests , Mutagens
9.
Neoplasma ; 34(2): 159-67, 1987.
Article in English | MEDLINE | ID: mdl-3110636

ABSTRACT

Betel leaf (Piper betel) water and acetone extract are nonmutagenic in S. typhimurium strains with and without S9 mix. Both the extracts suppress the mutagenicity of betel quid mutagens in a dose dependent manner. Moreover both the extracts of betel leaf reduce the mutagenicity of benzo(a)pyrene and dimethylbenzanthracene. Acetone extract is more potent than water extract in inhibiting mutagenicity of environmental mutagens.


Subject(s)
Areca , Mutagens , Plants, Medicinal , 9,10-Dimethyl-1,2-benzanthracene/antagonists & inhibitors , Acetone/pharmacology , Benzopyrenes/antagonists & inhibitors , Salmonella typhimurium/drug effects , Water/pharmacology
10.
Food Chem Toxicol ; 24(12): 1321-4, 1986 Dec.
Article in English | MEDLINE | ID: mdl-3100406

ABSTRACT

The phenolic compounds eugenol and hydroxychavicol were separated from betel leaf extract using C18 phase bonded Hiflosil silica gel. The structures of the two compounds were confirmed by nuclear magnetic resonance data. Neither eugenol nor hydroxychavicol was mutagenic when tested in various strains of Salmonella typhimurium with or without metabolic activation. Both compounds exhibited dose-dependent suppression of dimethylbenzanthracene-induced mutagenesis in S. typhimurium strain TA98 with metabolic activation. Hydroxychavicol was more potent than eugenol in this respect.


Subject(s)
Eugenol/analogs & derivatives , Eugenol/toxicity , Plant Extracts/toxicity , 9,10-Dimethyl-1,2-benzanthracene/antagonists & inhibitors , Animals , Dose-Response Relationship, Drug , Eugenol/isolation & purification , Magnetic Resonance Spectroscopy , Mutagenicity Tests , Mutation/drug effects , Plant Extracts/isolation & purification , Rats , Salmonella typhimurium
11.
Neoplasma ; 30(1): 35-42, 1983.
Article in English | MEDLINE | ID: mdl-6300708

ABSTRACT

Fine mince of embryonic rat tongue suspended in medium and transferred to culture vessel adhere immediately to surface. Epithelial and fibroblastic cell outgrowth seen in the first few days was overgrown with fibroblasts later. Evidence is presented that these fibroblasts are sensitive to post-confluence inhibition of division and exhibit several properties of normal fibroblasts including limited lifespan. This system may serve as a simple in vitro model for oral carcinogenesis studies.


Subject(s)
Carcinogens/toxicity , Drug Evaluation, Preclinical/methods , Tongue/drug effects , 9,10-Dimethyl-1,2-benzanthracene/toxicity , Animals , Benzo(a)pyrene , Benzopyrenes/toxicity , Cell Division/drug effects , Cells, Cultured , Cheek , Cricetinae , Female , Mesocricetus , Methylnitronitrosoguanidine/toxicity , Pregnancy , Rats , Rats, Inbred Strains , Tongue/embryology
SELECTION OF CITATIONS
SEARCH DETAIL